Addex Therapeutics to Report Third Quarter 2022 Financial :

Geneva, Switzerland, November 3, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...

Related Keywords

Geneva , Genè , Switzerland , United States , American , Swiss , Tim Dyer , Mike Sinclair , Janssen Pharmaceuticals Inc , Swiss Exchange , Nasdaq , Addex Therapeutics , Announce Third Quarter , Provides Corporate , Conference Call , Participant Dial In , Janssen Pharmaceuticals , American Depositary Shares , Swiss Stock Exchange Adxn ,